arrow
P

Peter Sinnaeve

Department of Cardiovascular Sciences
H指数:52
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Carotid Atherosclerosis and Aortic Stiffness in Masters Athletes: Multimodality Vascular Phenotyping from the Master@Heart Study

颈动脉动脉粥样硬化和主动脉僵硬度在大师级运动员中的多模态血管表型分析:Master@Heart研究

2026-07-250
OAAI
Acute strenuous exercise does not meaningfully influence lipoprotein(a)-based cardiovascular risk classification in endurance athletes

急性剧烈运动不会显著影响耐力运动员基于脂蛋白(a)的心血管风险分类

2026-07-180
OAAI
International practices; barriers; and enablers for patient and public involvement in pricing and reimbursement decision-making: a mixed-methods study

国际实践;障碍;以及患者和公众参与定价和报销决策制定的促进因素:一项混合方法研究

2026-04-210
OA
Rescue percutaneous coronary intervention in the pharmaco-invasive era of ST-elevation myocardial infarction: insights from the STREAM-2 trial

ST段抬高型心肌梗死药溶时代经皮冠状动脉介入治疗的补救措施:STREAM-2试验的启示

2025-12-010
PRE
The role of lipoprotein(a) in predicting coronary artery disease among ageing endurance athletes and healthy controls

脂蛋白(a)在预测老年耐力运动员和健康对照组冠状动脉疾病中的作用

2025-11-010
PRE
Pharmaco-Invasive Strategy With Half-Dose Tenecteplase in Patients With STEMI: Prespecified Pooled Analysis of Patients Aged ≥75 Years in STREAM-1 and 2

在STEMI患者中使用半剂量tenectepase的药物侵入性策略: STREAM-1和2中年龄 ≥ 75岁的患者的预设汇总分析

2024-12-010
PRE
Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: Rationale and design of the COL BE PCI trial
2024-12-011
PRE
Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up
2024-10-010
PRE
An interventional sheep model of severe aortic valve stenosis hemodynamics for the evaluation of alterations in coronary physiology and microvascular function

重度主动脉瓣狭窄的介入绵羊模型,用于评估冠状动脉生理和微血管功能的改变

2024-03-013
PRE
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial
2023-08-2923
OA
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry
2023-01-011
OAAI